Vitamin D levels in systemic sclerosis patients: A meta-analysis

Drug Design, Development and Therapy

Volumn 11, Issue , 2017, Pages 3119-3125

  An, Lin ^a   Sun, Ming Hui ^a   Chen, Feng ^a   Li, Jin Ran ^a  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Meta analysis; Systemic sclerosis; Vitamin D

Indexed keywords

VITAMIN D;

CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; DIFFUSED TYPE SYSTEMIC SCLEROSIS; DIGESTIVE SYSTEM ULCER; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; LIMITED TYPE SYSTEMIC SCLEROSIS; LUNG FIBROSIS; LUNG PRESSURE; META ANALYSIS (TOPIC); REVIEW; STANDARDIZATION; SYSTEMATIC REVIEW; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL; VITAMIN D BLOOD LEVEL; VITAMIN D DEFICIENCY; BLOOD; META ANALYSIS;

HUMANS; SCLERODERMA, SYSTEMIC; VITAMIN D;

EID: 85034669214     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: 10.2147/DDDT.S144860     Document Type: Review

References (25)

1. Dankers W, Colin EM, van Hamburg JP, Lubberts E. Vitamin D in autoimmunity: molecular mechanisms and therapeutic potential. Front Immunol. 2017;7:697.
2. Arnson Y, Amital H, Shoenfeld Y. Vitamin D and autoimmunity: new aetiological and therapeutic considerations. Ann Rheum Dis. 2007;66(9):1137-1142.
3. Holick MF, Chen TC, Lu Z, Sauter E. Vitamin D and skin physiology: a D-lightful story. J Bone Miner Res. 2007;22 (Suppl 2):V28-V33.
4. Upala S, Sanguankeo A. Low 25-hydroxyvitamin D levels are associated with vitiligo: a systematic review and meta-analysis. Photodermatol Photoimmunol Photomed. 2016;32(4):181-190.
5. Veldman CM, Cantorna MT, DeLuca HF. Expression of 1,25-dihydroxyvitamin D3 receptor in the immune system. Arch Biochem Biophys. 2000;374(2):334-338.
6. Morgan JW, Kouttab N, Ford D, Maizel AL. Vitamin D-mediated gene regulation in phenotypically defined B cells subpopulations. Endocrinology. 2000;141(9):3225-3234.
7. Cutolo M. Further emergent evidence for the vitamin D endocrine system involvement in autoimmune rheumatic disease risk and prognosis. Ann Rheum Dis. 2013;72(4):473-475.
8. Elhai M, Avouac J, Kahan A, Allanore Y. Systemic sclerosis: recent insights. Joint Bone Spine. 2015;82(3):148-153.
9. Denton CP. Advances in pathogenesis and treatment of systemic sclerosis. Clin Med (Lond). 2016;16(1):55-60.
10. Giuggioli D, Colaci M, Cassone G, et al. Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature. Clin Rheumatol. 2017;36(3):583-590.
11. Montabone E, Data V, Carignola R. Vitamin D status and quality of life in systemic sclerosis patients. J Clin Rheumatol. 2016;22(4):229-230.
12. Bivona G, Agnello L, Pivetti A, et al. Association between hypovitaminosis D and systemic sclerosis: true or fake? Clin Chim Acta. 2016;458:115-119.
13. Zhang L, Duan Y, Zhang TP, et al. Association between the serum level of vitamin D and systemic sclerosis in a Chinese population: a case control study. Int J Rheum Dis. 2017;20(8):1002-1008.
14. Shinjo SK, Bonfá E, de Falco Caparbo V, Pereira RM. Low bone mass in juvenile onset sclerosis systemic: the possible role for 25hydroxyvitamin D insufficiency. Rheumatol Int. 2011;31(8):1075-1080.
15. Corrado A, Colia R, Mele A, et al. Relationship between body mass composition, bone mineral density, skin fibrosis and 25(OH) vitamin D serum levels in systemic sclerosis. PLoS One. 2015;10(11):e0142748.
16. Seriolo B, Molfetta L, Cutolo M. Seasonal variations in serum levels of 25-hydroxyvitamin D in patients with systemic sclerosis. Clin Rheumatol. 2011;30(3):445-446.
17. Arnson Y, Amital H, Agmon-Levin N, et al. Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. Autoimmun Rev. 2011;10(8):490-494.
18. Atteritano M, Santoro D, Corallo G, et al. Skin involvement and pulmonary hypertension are associated with vitamin D insufficiency. Int J Mol Sci. 2016;17(12):2103.
19. Caramaschi P, Dalla Gassa A, Ruzzenente O, et al. Very low levels of vitamin D in systemic sclerosis patients. Clin Rheumatol. 2010;29(12):1419-1425.
20. Groseanu L, Bojinca V, Gudu T, et al. Low vitamin D status in systemic sclerosis and the impact on disease phenotype. Eur J Rheumatol. 2016;3(2):50-55.
21. Yang CY, Leung PS, Adamopoulos IE, Gershwin ME. The implication of vitamin D and autoimmunity: a comprehensive review. Clin Rev Allergy Immunol. 2013;45(2):217-226.
22. Fernandes de Abreu DA, Eyles D, Féron F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology. 2009;34 (Suppl 1):S265-S277.
23. Vacca A, Cormier C, Piras M, Mathieu A, Kahan A, Allanore Y. Vitamin D deficiency and insufficiency in 2 independent cohorts of patients. J Rheumatol. 2009;36(9):1924-1929.
24. Robberecht E, Vandewalle S, Wehlou C, Kaufman JM, De Schepper J. Sunlight is an important determinant of vitamin D serum concentrations in cystic fibrosis. Eur J Clin Nutr. 2011;65(5):574-579.
25. Bogh MK, Gullstrand J, Svensson A, Ljunggren B, Dorkhan M. Narrowband ultraviolet B three times per week is more effective in treating vitamin D deficiency than 1600 IU oral vitamin D3 per day: a randomized clinical trial. Br J Dermatol. 2012;167(9):625-630.